← Back to All Filings

Director Files to Sell $218K in Universal Health Services Stock

Low SignificanceOctober 29, 2025 at 4:33:29 PM EDT

UNIVERSAL HEALTH SERVICES INC

$UHS144CIK: 0000352915

Subscribe to track UHS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Director Files to Sell $218K in Universal Health Services Stock

Company: UNIVERSAL HEALTH SERVICES INC (UHS) Form: 144 | Filed: 2025-10-29 Significance: Low

Insider: SUSSMAN ELLIOT J MD MBA Title: null | Relationship: Director

Transaction: • Type: Proposed Sale • Shares: 965 • Price: ~$225.70 • Value: $217,798.67 • Owned After: Not Disclosed

Key Insight: A director has filed a notice of a proposed sale of shares valued at approximately $218k. The transaction size is negligible compared to the company's $13.41B market cap, representing less than 0.002% of market value and shares outstanding.

Market Context: This is a routine filing for a small disposition of shares and is not considered a significant indicator of the insider's outlook on the company.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: UNIVERSAL HEALTH SERVICES INC

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director filed a notice of a proposed sale of 965 shares, valued at approximately $218k. The transaction is immaterial relative to the company's size and the insider's role.
  • Market Impact: The transaction is too small to have any meaningful impact on the stock price or market sentiment.

Company Information

FieldValue
CompanyUNIVERSAL HEALTH SERVICES INC
Ticker SymbolUHS (Inferred)
CIK0000352915
IndustrySERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC

Insider Information

FieldValue
NameSUSSMAN ELLIOT J MD MBA
CIK0001181000
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type144
Transaction Date2025-10-29
Transaction Codenull
Security TypeCommon
Shares Involved965
Price Per Share~$225.70
Total Value$217,798.67
Shares Owned Afternull
Ownership Typenull

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$217,798.67
% of Market Cap0.0016%
Shares Transacted965
% of Shares Outstanding0.0017%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $13.41 billion, this transaction of approximately $218k is financially negligible. It does not represent a significant capital reallocation by the insider.
  • Ownership Concentration: Without post-transaction ownership data, a full assessment is not possible. However, the size of the sale is extremely small relative to the 56.39 million shares outstanding.
  • Dilution Impact: Not applicable, as this is a sale of existing shares, not an issuance.
  • Transaction Significance: The sale represents just 0.0016% of the company's market cap and 0.0017% of its shares outstanding. These figures are well below the thresholds for even moderate significance, categorizing this as a routine, low-impact event.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A Form 144 filing for a sale of this small size is unlikely to influence investor behavior. It is typically viewed as a personal liquidity event for the insider rather than a strategic move based on company performance.

Volume & Sentiment

  • Expected Volume Impact: None. The number of shares is too small to affect trading volume.
  • Sentiment Indicator: Neutral. The market will likely disregard this filing due to its immateriality.

Investment Insights

Positive Market Indicators

  • No positive indicators can be derived from this filing.

Risk Factors

  • No specific risk factors are highlighted by this routine transaction.

Key Takeaways

  1. Immaterial Transaction: The proposed sale by Director Elliot Sussman is valued at only $218k, which is insignificant for a company of Universal Health Services' scale.
  2. Form 144 Filing: This is a notice of a proposed sale, a standard procedure for affiliates selling restricted securities. It does not always mean the sale will execute immediately or at the specified price.
  3. No Change in Thesis: This filing provides no new information to alter an investment thesis on the company. It is a non-event from a strategic analysis perspective.

Additional Context

Transaction Notes

  • The filing indicates the shares to be sold were originally acquired via a stock option exercise on the same day as the proposed sale date.
  • Special Circumstances: No 10b5-1 plan was mentioned in the filing.
  • Market Environment: The filing should be viewed as a routine insider transaction for portfolio management or personal financial planning.
Topics:#SECFiling#InsiderTrading#UHS#Form144#InsiderSell#StockMarket#Investing#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.